Overview

Dexamethasone in Lower Third Molar Surgery

Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized double-blind cross over clinical trial is to investigate effectiveness of different routes of applications (intramuscular and submucous at the site of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of life after lower third molar surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of Belgrade
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate